Detalhe da pesquisa
1.
PHASE 2 RANDOMIZED STUDY (ORION-1) OF A NOVEL, BIODEGRADABLE DEXAMETHASONE IMPLANT (AR-1105) FOR THE TREATMENT OF MACULAR EDEMA DUE TO CENTRAL OR BRANCH RETINAL VEIN OCCLUSION.
Retina
; 43(1): 25-33, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542081